Physician

Seyoum Daffo Bage, M.D.

According to 2025 Medicare claims, Seyoum Bage, M.D. (NPI: 1609842640) practices infectious disease in the Parkersburg-Vienna, WV market, with the plurality of this provider's patient population coming from Wood, WV. This provider's primary affiliated billing organization is CAMDEN-CLARK PHYSICIAN CORPORATION (NPI: 1710125430; TIN: 264058719) and primary practice location at 26101-0718. Bage is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Bage's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 423 traditional Medicare patients, billed 1,490 HCPCS/CPT codes, and received $91,856 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 610 prescription claims across 136 beneficiaries totaling $349,435 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 49 records totaling $1,126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $439,353 to $91,856. Similarly, Part D prescription costs have fallen sharply in recent years, from $1,412,533 to $349,435. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,403	7,751	$439,353
2016	1,493	6,016	$404,922
2017	1,555	5,831	$395,735
2018	1,494	5,321	$367,445
2019	1,320	5,842	$389,846
2020	1,153	4,812	$322,432
2021	995	4,091	$273,272
2022	656	2,282	$154,155
2023	473	1,580	$102,230
2024	423	1,490	$91,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	282	1,124	$1,412,533
2016	319	1,270	$2,432,206
2017	369	1,438	$2,780,884
2018	319	1,321	$2,299,125
2019	282	1,335	$2,576,570
2020	257	1,309	$1,852,766
2021	255	1,169	$1,779,541
2022	214	1,065	$1,235,649
2023	192	870	$765,019
2024	136	610	$349,435

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	173	200	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	128	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	85	111	$59
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	260	759	$54
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	84	158	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	37	1,110	$156,845
Daptomycin	Daptomycin	30	197	$45,527
Dovato	Dolutegravir Sodium/Lamivudine	11	330	$32,172
Tivicay	Dolutegravir Sodium	12	360	$26,426
Ertapenem	Ertapenem Sodium	13	80	$8,255

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$1,126	Melinta Therapeutics, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Seyoum Daffo Bage, M.D.?

Tedicare shows public-source Medicare data for Seyoum Daffo Bage, M.D. (NPI 1609842640), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Seyoum Daffo Bage, M.D. have ACO affiliation data?

Seyoum Daffo Bage, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Seyoum Daffo Bage, M.D.?

Seyoum Daffo Bage, M.D. is linked to CAMDEN-CLARK PHYSICIAN CORPORATION (billing NPI 1710125430) in the available physician profile data.

Does Seyoum Daffo Bage, M.D. have Open Payments data?

Seyoum Daffo Bage, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.